CSL Joins Accumulus Synergy to Drive Industry Change
September 17 2024 - 8:05AM
UK Regulatory
CSL Joins Accumulus Synergy to Drive Industry Change
Following the launch of Accumulus Synergy’s innovative
cloud-based information exchange platform, CSL joins the nonprofit
industry association
BURLINGAME, Calif., Sept. 17, 2024 (GLOBE
NEWSWIRE) -- Accumulus Synergy, Inc. (“Accumulus”), and its
Founding Sponsors are proud to welcome CSL as its first member
organization. This collaboration marks significant progress in
collectively bringing together industry stakeholders to advance the
mission of dramatically accelerating critical therapies to citizens
of the world.
"We are honored to welcome CSL to our member
community,” commented Frank Nogueira, Accumulus Chief Executive
Officer. “A membership with Accumulus is an investment in the
ecosystem. We closely engage with national regulatory agencies
(NRAs), trade associations, life sciences organizations, and
non-governmental organizations (NGOs) within the global regulatory
environment to accelerate regulatory exchange and data
harmonization. In industries as dynamic and rapidly evolving as
pharmaceuticals, science, and technology, being part of a strong,
innovative network is essential.”
The Accumulus membership model is designed to
help shape regulatory policy and raise awareness of the need for
global harmonization of regulatory requirements and data standards.
Ultimately, these efforts drive digital transformation to
accelerate therapies to patients worldwide. With a shared
commitment to advancing these interests, both Accumulus and CSL are
well-poised to amplify their collective impact and drive positive
change on a global scale.
“Accumulus Synergy is a catalyst for change.
Leading with purpose and vision, Accumulus is not
merely innovating but pioneering an industry paradigm shift
for regulatory harmonization and digital transformation,” said
Emmanuelle Lecomte-Brisset, Global Head of Regulatory Affairs at
CSL.
Membership is now open to participants within
the regulatory ecosystem, including life sciences organizations,
health associations, private/non-profit foundations, and other
institutions. Accumulus offers member organizations unparalleled
access to valuable resources, thought leadership, networking
opportunities, and policy-shaping efforts tailored to industry
needs.
“We are excited to see our community expand and
our work focus on collectively advancing opportunities for
regulatory data convergence, data harmonization, and digital
transformation,” said Khushboo Sharma, Accumulus Chief Regulatory
Innovation Officer. “With a steadfast dedication to innovation and
collaboration, it is a privilege to have CSL join us.”
To learn more about membership and subscription
opportunities with Accumulus Synergy, contact us at
info@accumulus.org.
About Accumulus Synergy
Accumulus Synergy is a global, nonprofit industry association
developing a transformative data exchange platform that aims to
enable enhanced collaboration and efficiency between life sciences
organizations and global Regulatory Authorities while also
affording users the ability to extract dynamic, data-driven
insights. Accumulus is working with key stakeholders in the life
sciences-regulatory ecosystem to build and sustain a platform that
aims to meet regulatory, cybersecurity, and privacy requirements
spanning clinical, safety, chemistry, and manufacturing and
regulatory exchanges and submissions. Accumulus Synergy Sponsors
include leading global pharmaceutical companies.
About CSL
CSL (ASX:CSL; USOTC:CSLLY) is a global biotechnology company
with a dynamic portfolio of lifesaving medicines, including
those that treat hemophilia and immune deficiencies, vaccines to
prevent influenza, and therapies in iron deficiency and nephrology.
Since our start in 1916, we have been driven by our promise to save
lives using the latest technologies. Today, CSL – including our
three businesses: CSL Behring, CSL Seqirus, and CSL Vifor –
provides lifesaving products to patients in more than 100 countries
and employs 32,000 people. Our unique combination of commercial
strength, R&D focus, and operational excellence enables us to
identify, develop, and deliver innovations so our patients can live
life to the fullest. For more information about CSL,
visit CSL.com.
Media Contact
Allison Mari
allison.mari@accumulus.org
540-907-6053